Trial intelligence / Profile preview

Preconceptional orlistat treatment and IVF outcomes in overweight women

ChiCTR-IPR-17011629Phase 4Not yet recruiting

Sponsor
Reproductive Hospital affiliated with Shandong University
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in obesity and female infertility comparing Orlistat group with Placebo group (2 arms). Primary endpoint: live birth rate. Planned start Jul 2017; status: not yet recruiting.

02

Drugs

orlistat
03

Conditions

obesityfemale infertility

Beyond the preview

Go deeper on ChiCTR-IPR-17011629.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17011629.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call